Announcements Trials

Browse Landscape

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 3 Breast Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 2 Uterine Cervical Neoplasms 1 Thyroid Cancer, Papillary 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Pleuropulmonary blastoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphedema 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Duodenal Neoplasms 1 Carcinoma, Lobular 1 Anatomic Stage III Breast Cancer AJCC v8 1 Anatomic Stage II Breast Cancer AJCC v8 1 Adenocarcinoma, Follicular 1

Interventions

Cisplatin 22 pembrolizumab 21 Carboplatin 12 Radiotherapy 11 Paclitaxel 11 Brachytherapy 11 Drug Therapy 10 Bevacizumab 9 Blood Specimen Collection 7 Colposcopy 6 Specimen Handling 5 Injections 5 toripalimab 4 Taxes 4 Surveys and Questionnaires 4 Nivolumab 4 Mass Screening 4 Human Papillomavirus DNA Tests 4 Gemcitabine 4 Chemotherapy, Adjuvant 4 Chemoradiotherapy 4 spartalizumab 3 lenvatinib 3 camrelizumab 3 aldesleukin 3 Restraint, Physical 3 Radiation 3 Fulvestrant 3 Cyclophosphamide 3 Biopsy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Uterine Cervical Neoplasms × High-Energy Shock Waves × Clear all

NCT07120529 2025-08-13

MOOSE

Medical University of Silesia

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡